MaxCyte (MXCT) has a debt-to-equity ratio of 0.12, below the Materials sector average of 0.93.
Get informed when a big investor buys or sells
+ Follow0.12
Debt-to-Equity ratio measures a company's financial leverage by comparing its total debt to shareholder equity. A lower D/E ratio generally indicates a more financially stable company with less risk.
MaxCyte (MXCT) currently reports a debt-to-equity ratio of 0.12. That is below the Materials sector average of 0.93. Use the charts on this page to explore MaxCyte's debt-to-equity ratio history and peer comparisons.
MaxCyte's debt-to-equity ratio of 0.12 is lower than the Materials sector average of 0.93. That is roughly 86.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The debt-to-equity ratio is a valuation multiple that relates MaxCyte's market price to a fundamental measure such as earnings, sales, or book value. At 0.12, MXCT can look expensive or cheap only in context — versus its own history, growth rate, and Materials peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current debt-to-equity ratio of 0.12, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 0.93. From there, open related valuation or income-statement pages for MaxCyte, and consider following MXCT for alerts when major investors trade the stock.
MaxCyte is classified in the Materials sector. On debt-to-equity ratio, it currently shows 0.12 versus a sector average near 0.93. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing MXCT with unrelated industries.